Treatment of locally recurrent rectal adenocarcinoma
- Christopher G Willett, MD
Christopher G Willett, MD
- Section Editor — Radiation Therapy
- Duke University Medical School
- Miguel A Rodriguez-Bigas, MD
Miguel A Rodriguez-Bigas, MD
- Professor of Surgery
- MD Anderson Cancer Center
- David P Ryan, MD
David P Ryan, MD
- Professor of Medicine
- Harvard Medical School
Approximately 39,220 Americans are diagnosed with rectal cancer annually . The vast majority of these are adenocarcinomas.
Surgical resection is the cornerstone of curative therapy for patients with potentially resectable rectal cancer. Radiation therapy (RT) with concurrent fluoropyrimidine chemotherapy has emerged as an important component of curative therapy for transmural or node-positive rectal cancer because in contrast to colon cancer, in which the failure pattern is predominantly distant, the site of first failure in patients undergoing surgery for rectal cancer is equally distributed locally (ie, pelvis) and in distant sites (eg, liver, lung) . Chemoradiotherapy is often administered preoperatively for clinically staged T3 or T4 (table 1), or node-positive tumors, for distal tumors, in which tumor regression may allow successful conversion of a planned abdominopelvic resection (APR) to a sphincter-sparing surgical procedure, or if the preoperative staging evaluation suggests mesorectal invasion. Preoperative, as compared with postoperative, chemoradiotherapy results in a superior sphincter preservation rate, a lower rate of anastomotic stenosis, and better local control while providing similar long-term survival. (See "Neoadjuvant chemoradiotherapy and radiotherapy for rectal adenocarcinoma", section on 'Indications for neoadjuvant treatment' and "Pretreatment local staging evaluation for rectal cancer", section on 'Assessing T and N stage, and the status of the CRM' and "Adjuvant therapy for resected rectal adenocarcinoma".)
Despite refinements in surgical techniques (such as total mesorectal excision [TME]) and optimal use of neoadjuvant and adjuvant therapies, the incidence of locoregional relapse after initial treatment of invasive rectal cancer is still 4 to 8 percent [3,4]. (See "Rectal cancer: Surgical principles", section on 'Total mesorectal excision'.)
Treatment of locally recurrent rectal cancer will be discussed here. Neoadjuvant chemoradiotherapy for potentially resectable primary adenocarcinomas, adjuvant therapy after resection of a primary rectal adenocarcinoma, pretreatment local staging evaluation, surgical principles, and recommendations for posttreatment surveillance are discussed elsewhere, as is the management of rectal squamous cell cancers. (See "Neoadjuvant chemoradiotherapy and radiotherapy for rectal adenocarcinoma" and "Pretreatment local staging evaluation for rectal cancer" and "Rectal cancer: Surgical principles" and "Adjuvant therapy for resected rectal adenocarcinoma" and "Surveillance after colorectal cancer resection" and "Clinical features, staging, and treatment of anal cancer", section on 'Rectal squamous cell cancers'.)
THE CHALLENGE OF LOCALLY RECURRENT RECTAL CANCER
Management of locally recurrent rectal adenocarcinoma is a significant challenge for a number of reasons.
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016; 66:7.
- Minsky BD, Mies C, Recht A, et al. Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival. Cancer 1988; 61:1408.
- Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 2009; 373:811.
- Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345:638.
- Camilleri-Brennan J, Steele RJ. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 2001; 27:349.
- Kusters M, Marijnen CA, van de Velde CJ, et al. Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial. Eur J Surg Oncol 2010; 36:470.
- Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007; 246:693.
- Folkesson J, Birgisson H, Pahlman L, et al. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005; 23:5644.
- Holm T, Cedermark B, Rutqvist LE. Local recurrence of rectal adenocarcinoma after 'curative' surgery with and without preoperative radiotherapy. Br J Surg 1994; 81:452.
- van den Brink M, Stiggelbout AM, van den Hout WB, et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 2004; 22:3958.
- Tanis PJ, Doeksen A, van Lanschot JJ. Intentionally curative treatment of locally recurrent rectal cancer: a systematic review. Can J Surg 2013; 56:135.
- Rombouts AJ, Koh CE, Young JM, et al. Does radiotherapy of the primary rectal cancer affect prognosis after pelvic exenteration for recurrent rectal cancer? Dis Colon Rectum 2015; 58:65.
- Henry LR, Sigurdson E, Ross EA, et al. Resection of isolated pelvic recurrences after colorectal surgery: long-term results and predictors of improved clinical outcome. Ann Surg Oncol 2007; 14:1081.
- Hahnloser D, Nelson H, Gunderson LL, et al. Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 2003; 237:502.
- Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007; 14:447.
- Heriot AG, Byrne CM, Lee P, et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 2008; 51:284.
- Hashiguchi Y, Sekine T, Sakamoto H, et al. Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 1999; 42:886.
- Kim YW, Kim NK, Min BS, et al. Factors associated with anastomotic recurrence after total mesorectal excision in rectal cancer patients. J Surg Oncol 2009; 99:58.
- Chessin DB, Kiran RP, Akhurst T, Guillem JG. The emerging role of 18F-fluorodeoxyglucose positron emission tomography in the management of primary and recurrent rectal cancer. J Am Coll Surg 2005; 201:948.
- Watson AJ, Lolohea S, Robertson GM, Frizelle FA. The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum 2007; 50:102.
- Faneyte IF, Dresen RC, Edelbroek MA, et al. Pre-operative staging with positron emission tomography in patients with pelvic recurrence of rectal cancer. Dig Surg 2008; 25:202.
- Dresen RC, Kusters M, Daniels-Gooszen AW, et al. Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging. Radiology 2010; 256:143.
- Messiou C, Chalmers AG, Boyle K, et al. Pre-operative MR assessment of recurrent rectal cancer. Br J Radiol 2008; 81:468.
- Bouchard P, Efron J. Management of recurrent rectal cancer. Ann Surg Oncol 2010; 17:1343.
- Suzuki K, Dozois RR, Devine RM, et al. Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 1996; 39:730.
- Moore HG, Shoup M, Riedel E, et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 2004; 47:1599.
- Boyle KM, Sagar PM, Chalmers AG, et al. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005; 48:929.
- Ito Y, Ohtsu A, Ishikura S, et al. Efficacy of chemoradiotherapy on pain relief in patients with intrapelvic recurrence of rectal cancer. Jpn J Clin Oncol 2003; 33:180.
- Larsen SG, Wiig JN, Tretli S, Giercksky KE. Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age. Colorectal Dis 2006; 8:177.
- Rhomberg W, Eiter H, Hergan K, Schneider B. Inoperable recurrent rectal cancer: results of a prospective trial with radiation therapy and razoxane. Int J Radiat Oncol Biol Phys 1994; 30:419.
- Bakx R, Visser O, Josso J, et al. Management of recurrent rectal cancer: a population based study in greater Amsterdam. World J Gastroenterol 2008; 14:6018.
- Sagar PM, Gonsalves S, Heath RM, et al. Composite abdominosacral resection for recurrent rectal cancer. Br J Surg 2009; 96:191.
- Hansen MH, Balteskard L, Dørum LM, et al. Locally recurrent rectal cancer in Norway. Br J Surg 2009; 96:1176.
- Tepper JE, O'Connell M, Hollis D, et al. Analysis of surgical salvage after failure of primary therapy in rectal cancer: results from Intergroup Study 0114. J Clin Oncol 2003; 21:3623.
- Ferenschild FT, Vermaas M, Verhoef C, et al. Abdominosacral resection for locally advanced and recurrent rectal cancer. Br J Surg 2009; 96:1341.
- Bhangu A, Brown G, Akmal M, Tekkis P. Outcome of abdominosacral resection for locally advanced primary and recurrent rectal cancer. Br J Surg 2012; 99:1453.
- Colibaseanu DT, Mathis KL, Abdelsattar ZM, et al. Is curative resection and long-term survival possible for locally re-recurrent colorectal cancer in the pelvis? Dis Colon Rectum 2013; 56:14.
- Alberda WJ, Verhoef C, Nuyttens JJ, et al. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor. Ann Surg Oncol 2014; 21:520.
- Bakx R, van Tinteren H, van Lanschot JJ, Zoetmulder FA. Surgical treatment of locally recurrent rectal cancer. Eur J Surg Oncol 2004; 30:857.
- Bikhchandani J, Ong GK, Dozois EJ, Mathis KL. Outcomes of salvage surgery for cure in patients with locally recurrent disease after local excision of rectal cancer. Dis Colon Rectum 2015; 58:283.
- Perez RO, Habr-Gama A, São Julião GP, et al. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence. Ann Surg Oncol 2016; 23:1143.
- Asoglu O, Karanlik H, Muslumanoglu M, et al. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 2007; 33:1199.
- Caricato M, Borzomati D, Ausania F, et al. Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol 2006; 32:126.
- Mirnezami AH, Sagar PM, Kavanagh D, et al. Clinical algorithms for the surgical management of locally recurrent rectal cancer. Dis Colon Rectum 2010; 53:1248.
- Park JK, Kim YW, Hur H, et al. Prognostic factors affecting oncologic outcomes in patients with locally recurrent rectal cancer: impact of patterns of pelvic recurrence on curative resection. Langenbecks Arch Surg 2009; 394:71.
- Dresen RC, Gosens MJ, Martijn H, et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 2008; 15:1937.
- Colibaseanu DT, Dozois EJ, Mathis KL, et al. Extended sacropelvic resection for locally recurrent rectal cancer: can it be done safely and with good oncologic outcomes? Dis Colon Rectum 2014; 57:47.
- Milne T, Solomon MJ, Lee P, et al. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer. Ann Surg 2013; 258:1007.
- Wasserberg N, Kaiser AM, Nunoo-Mensah JW, et al. Preservation of bowel and urinary continence in the management of locally recurrent rectal cancer. J Surg Oncol 2005; 92:76.
- Koda K, Tobe T, Takiguchi N, et al. Pelvic exenteration for advanced colorectal cancer with reconstruction of urinary and sphincter functions. Br J Surg 2002; 89:1286.
- Rahbari NN, Ulrich AB, Bruckner T, et al. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Ann Surg 2011; 253:522.
- Harris CA, Solomon MJ, Heriot AG, et al. The Outcomes and Patterns of Treatment Failure After Surgery for Locally Recurrent Rectal Cancer. Ann Surg 2016; 264:323.
- Saito N, Koda K, Takiguchi N, et al. Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 2003; 20:192.
- Gunderson LL, Nelson H, Martenson JA, et al. Intraoperative electron and external beam irradiation with or without 5-fluorouracil and maximum surgical resection for previously unirradiated, locally recurrent colorectal cancer. Dis Colon Rectum 1996; 39:1379.
- Rades D, Kuhn H, Schultze J, et al. Prognostic factors affecting locally recurrent rectal cancer and clinical significance of hemoglobin. Int J Radiat Oncol Biol Phys 2008; 70:1087.
- Rödel C, Grabenbauer GG, Matzel KE, et al. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 2000; 43:312.
- Stocchi L, Nelson H, Sargent DJ, et al. Is en-bloc resection of locally recurrent rectal carcinoma involving the urinary tract indicated? Ann Surg Oncol 2006; 13:740.
- Wiig JN, Tveit KM, Poulsen JP, et al. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002; 62:207.
- Braendengen M, Tveit KM, Berglund A, et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26:3687.
- You YT, Chen JS, Wang JY, et al. Concurrent chemoradiotherapy in the treatment of locally recurrent rectal cancer. Hepatogastroenterology 2013; 60:94.
- Valentini V, Coco C, Rizzo G, et al. Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience. Surgery 2009; 145:486.
- Nakfoor BM, Willett CG, Shellito PC, et al. The impact of 5-fluorouracil and intraoperative electron beam radiation therapy on the outcome of patients with locally advanced primary rectal and rectosigmoid cancer. Ann Surg 1998; 228:194.
- Mathis KL, Nelson H, Pemberton JH, et al. Unresectable colorectal cancer can be cured with multimodality therapy. Ann Surg 2008; 248:592.
- Kim HK, Jessup JM, Beard CJ, et al. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys 1997; 38:777.
- Roeder F, Treiber M, Oertel S, et al. Patterns of failure and local control after intraoperative electron boost radiotherapy to the presacral space in combination with total mesorectal excision in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 2007; 67:1381.
- Kusters M, Holman FA, Martijn H, et al. Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment. Radiother Oncol 2009; 92:221.
- Hyngstrom JR, Tzeng CW, Beddar S, et al. Intraoperative radiation therapy for locally advanced primary and recurrent colorectal cancer: ten-year institutional experience. J Surg Oncol 2014; 109:652.
- Alektiar KM, Zelefsky MJ, Paty PB, et al. High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 2000; 48:219.
- Mannaerts GH, Martijn H, Crommelin MA, et al. Intraoperative electron beam radiation therapy for locally recurrent rectal carcinoma. Int J Radiat Oncol Biol Phys 1999; 45:297.
- Haddock MG, Miller RC, Nelson H, et al. Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 2011; 79:143.
- Tan J, Heriot AG, Mackay J, et al. Prospective single-arm study of intraoperative radiotherapy for locally advanced or recurrent rectal cancer. J Med Imaging Radiat Oncol 2013; 57:617.
- Roeder F, Goetz JM, Habl G, et al. Intraoperative Electron Radiation Therapy (IOERT) in the management of locally recurrent rectal cancer. BMC Cancer 2012; 12:592.
- Holman FA, Bosman SJ, Haddock MG, et al. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres. Eur J Surg Oncol 2016.
- Wallace HJ 3rd, Willett CG, Shellito PC, et al. Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. J Surg Oncol 1995; 60:122.
- Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 2002; 95:1144.
- Guren MG, Undseth C, Rekstad BL, et al. Reirradiation of locally recurrent rectal cancer: a systematic review. Radiother Oncol 2014; 113:151.
- Das P, Delclos ME, Skibber JM, et al. Hyperfractionated accelerated radiotherapy for rectal cancer in patients with prior pelvic irradiation. Int J Radiat Oncol Biol Phys 2010; 77:60.
- Bosman SJ, Holman FA, Nieuwenhuijzen GA, et al. Feasibility of reirradiation in the treatment of locally recurrent rectal cancer. Br J Surg 2014; 101:1280.
- Susko M, Lee J, Salama J, et al. The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer. Ann Surg Oncol 2016; 23:3609.
- Sun DS, Zhang JD, Li L, et al. Accelerated hyperfractionation field-involved re-irradiation combined with concurrent capecitabine chemotherapy for locally recurrent and irresectable rectal cancer. Br J Radiol 2012; 85:259.
- Valentini V, Morganti AG, Gambacorta MA, et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys 2006; 64:1129.
- THE CHALLENGE OF LOCALLY RECURRENT RECTAL CANCER
- MODE OF PRESENTATION
- PRETREATMENT EVALUATION
- Classification of recurrence pattern
- Surgical resection
- Combined modality therapy
- - Patients with no prior RT
- Role of intraoperative RT
- - Outcomes in previously irradiated patients
- - Benefit of adjuvant chemotherapy
- PALLIATION OF OBSTRUCTIVE SYMPTOMS DUE TO LOCALLY ADVANCED DISEASE
- INFORMATION FOR PATIENTS
- SUMMARY AND RECOMMENDATIONS